Welcome to LookChem.com Sign In|Join Free

CAS

  • or

906075-26-1

Post Buying Request

906075-26-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

906075-26-1 Usage

Class

Carboxamides

Appearance

White to off-white crystalline powder

Solubility

Soluble in water and organic solvents

Applications

a. Intermediate in the synthesis of pharmaceutical drugs
b. Reagent in organic chemistry reactions

Hazardous classification

Classified as a hazardous substance

Handling and storage

Requires careful management to avoid potential health and environmental risks

Check Digit Verification of cas no

The CAS Registry Mumber 906075-26-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,0,7 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 906075-26:
(8*9)+(7*0)+(6*6)+(5*0)+(4*7)+(3*5)+(2*2)+(1*6)=161
161 % 10 = 1
So 906075-26-1 is a valid CAS Registry Number.

906075-26-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Aminocycloheptanecarboxamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:906075-26-1 SDS

906075-26-1Downstream Products

906075-26-1Relevant articles and documents

Design and synthesis of certain substituted cycloalkanecarboxamides structurally related to safinamide with anticonvulsant potential

Aboul-Enein, Mohamed N.,El-Azzouny, Aida A.,Maklad, Yousreya A.,Ismail, Mohamed A.,Ismail, Nasser S. M.,Hassan, Rasha M.

, p. 3767 - 3791 (2015/06/08)

A series of novel safinamide derivatives were synthesized and biologically evaluated for their anticonvulsant activity against maximal electroshock seizure assay and subcutaneous pentylenetetrazole (s.c. PTZ) screening test. Compound 13b is the most active derivative in s.c. PTZ screening test with an ED50 value lower than that of safinamide by about tenfold. A molecular modeling study, including fitting to sodium channel blockers 3D-pharmacophore model and docking into a branched-chain aminotransferase enzyme active site were consistent with the in vivo results.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 906075-26-1